Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine in Elderly People
type: MedicalStudy
description: Observer-blind Safety and Immunogenicity Study of GlaxoSmithKline Biologicals' Influenza Vaccine GSK2186877A When Administered to Elderly Subjects
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2009-10-15
end date: 2010-05-27
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00992784
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: GlaxoSmithKline
study subject: Influenza
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Influenza

AI Analytics
type: Organization